1.The effect of mySugrTM mobile app on diabetes self-management in Filipino patients with Type 2 diabetes mellitus: A prospective single-arm interventional study.
Maria Honolina S. Gomez ; Nenuel Angelo B. Luna ; Dionise Ysabelle V. Bawal ; Marilyn Katrina C. Caro ; Ma. Felisse Carmen S. Gomez
Philippine Journal of Internal Medicine 2024;62(3):131-139
OBJECTIVE
To evaluate the effect of mySugrTM app on diabetes self-management, HbA1c level and its acceptability among app users with type 2 diabetes (T2DM).
METHODSA prospective, single-arm interventional study in 70 adult Filipino patients with T2DM and HbA1c ≥ 8.0%. Participants used the basic mySugrTM mobile app for 12 weeks. The Modified Behavior Score Instrument and the Diabetes Self-Management Questionnaire (DSMQ) pre- and post-intervention measured its impact on diabetes self-management while the Mobile Application rating Scale (MARS) assessed the quality of the app.
RESULTSThere was a significant increased adherence to the diabetes self-care behaviors. DSMQ showed that only 12% of the participants had poor self-care behaviors at week 12 particularly in physical activity and diet. The baseline median HbA1c [9.55% (8.43-11.30)] and estimated HbA1c [8.9% (8.3-10.9)] declined significantly after week 12, [8.0% (8.0-8.43)] and [7.2% (6.5-8.1)] respectively with a very significant p value of (p < 0.00001). About 42% of patients achieved an HbA1c level of ≤7%. MARS confirmed the app’s good quality and acceptability.
CONCLUSIONMobile application such as mySugrTM mobile app can be a viable tool for improved self-care behavior and help in achieving good glycemic control among patients with poorly controlled T2DM even as early as 12 weeks. The app has good quality and acceptability.
Human ; Diabetes Mellitus, Type 2
2.Diabetes knowledge among patients with type 2 diabetes at the University of Santo Tomas Hospital using the Filipino version of Michigan Diabetes Knowledge Test (Filipino-DKT).
Ma. Felisse Carmen S. GOMEZ ; Maria Honolina S. GOMEZ
Philippine Journal of Internal Medicine 2022;60(1):19-31
Background: A well-informed patient with Type 2 diabetes may be more compliant with treatment. This study aims to evaluate the diabetes-related knowledge and socio demographic determinants of patients seen at University of Santo Tomas Hospital through a translated and validated Filipino-DKT questionnaire.
Methods: Standard translation procedure was used to produce the Filipino version of the DKT2. A convenience sample of 112 outpatients with Type 2 diabetes was identified for six months at the University of Santo Tomas Hospital, Philippines. All data were collected using the Filipino-DKT and a demographic questionnaire.
Results: The Filipino-DKT demonstrated an acceptable Cronbach's alpha of 0.70 and an acceptable average inter-item correlation of 0.40 (p<0.001). The test-retest reliability was excellent, with a Pearson coefficient r of 1.00 (p<0.001). Our study demonstrated that of the 112 patients with diabetes who answered the general knowledge test, the majority had average knowledge of 78.64%, while 16.07% had poor knowledge. A total of 55 participants on insulin answered the second part of Filipino-DKT that measures insulin knowledge. Surprisingly, 56% of the subjects on insulin had poor knowledge, and only 7% had good knowledge. Results showed that the majority (56%) had poor knowledge. Participants who reported poor control of their diabetes (HbA1c >7%) also reported lower levels of knowledge about diabetes and insulin use. There was no association between duration of diabetes, family history of diabetes, and type of diabetes with knowledge of diabetes.
Conclusion: The Filipino diabetic knowledge of diabetes is poor and not related to age, sex, and duration of diabetes. Filipino-DKT is an acceptable, reliable, and valid measure of diabetes knowledge used in our clinical practice and research.
Diabetes Knowledge ; Translation ; Validation
3.painDETECT Questionnaire Filipino version: Transcultural adaptation and validation in two widely spoken regional languages (Tagalog and Cebuano)
Ma. Felisse Carmen S. Gomez ; Maria Faye Anne S. Gomez ; Maria Honolina S. Gomez ; Jocelyn C. Que ; Raymond L. Rosales
Neurology Asia 2019;24(1):21-30
Background & Objective: Chronic pain impacts the quality of life of patients, with neuropathic
pain causing profound negative sequelae. Assessment of pain whether nociceptive or neuropathic is
important to provide appropriate treatment. The objective of this study is to translate and validate the
pain-DETECT Questionnaire (PDQ) to two widely spoken regional languages in Filipino. Methods:
The PDQ, a self-administered questionnaire, was translated from English into the Filipino version,
painDETECT Tagalog (PDQ-Tag) and painDETECT Cebuano (PDQ-Ceb). One hundred Filipino
patients suffering from pain for at least three months were recruited in the out-patient clinics of a
hospital and completed the questionnaire. The investigators, blinded to the subjects PDQ-Tag and
PDQ-Ceb scores, examined the subjects using the standard clinical and neurological examination.
The PDQ-Tag and PDQ-Ceb, scores were validated. Both questionnaires were administered to the
same patient twice, two days apart by the same investigator. Results: Seventy subjects completed
the (PDQ-Tag) and thirty subjects the (PDQ-Ceb). The sensitivity and specificity of PDQ-Tag were
both 80% for an upper limit cut-off value of ≥ 17. The sensitivity and specificity of PDQ-Ceb were
62.5% and 80% respectively, for an upper limit cut-off value ≥ 18.0. Both questionnaires were reliable
[Cronbach’s alpha coefficient: 0.78 (PDQ-Tag) and 0.70 (PDQ-Ceb), good test-retest stability with
intra-class correlation coefficient: 0.93 for PDQ-Tag and 0.99 for PDQ-Ceb]. Cohen’s kappa were
0.64 and 0.61 for PDQ-Ceb and PDQ-Tag respectively, with P value<0.001 indicating a significant
agreement on the assessment of neuropathic pain.
Conclusion: PDQ-Tag and PDQ-Ceb are reliable and valid self-administered screening tools to detect
neuropathic pain among Filipinos.
4.Systemic hormonal unloading in unilateral adrenalectomy in a patient with bilateral adrenal hyperplasia: A case report
Ma. Felisse Carmen GOMEZ ; Florence Rochelle GAN ; Erick MENDOZA ; Leilani B MERCADO-ASIS
Journal of Medicine University of Santo Tomas 2019;3(1):303-308
Background :
Unilateral adrenalectomy has not
been recommended in the guidelines as a treatment
for primary hyperaldosteronism secondary to bilateral adrenal hyperplasia (BAH). Interestingly, recent
studies have shown that increased circulation of
aldosterone increased oxidative stress, cardiovascular (CV) complications such as atrial fi brillation,
myocardial infarction and heart failure; and that unilateral adrenalectomy led to improved CV function.
Therefore, recognizing the role of unilateral adrenalectomy in BAH, specifi cally for improved quality of
life is important.
Clinical case:
A 47‐year-old hypertensive (highest
blood pressure [BP] 150/90 mmHg) woman had a
severe headache, muscle weakness, polyuria, and polydipsia. Her serum potassium (K) was low at 3.1
mmol/L (3.5–5 mmol/L). Initial tests showed elevated plasma aldosterone, suppressed plasma renin activity and elevated aldosterone-renin ratio (6.61 ng/
dL, <0.1 ng/mL and 66, respectively). Plasma aldosterone after saline suppression test (12.70 ng/dL)
confi rmed the diagnosis of primary aldosteronism
(PA). MRI showed a well-defi ned, oval-shaped solid
nodule in the medial limb of the left adrenal gland
(1.8 x 1.2 cm). Bilateral adrenal vein sampling with
adrenocorticotropic hormone (ACTH) stimulation test
was compatible with BAH (cortisol-corrected aldosterone ratio pre-ACTH stimulation 1.29 and postACTH 1.66), with dominant aldosterone secreting
left adrenal gland (7200 vs 3760 ng/dL). She was
started on spironolactone 200 mg/day and amlodipine 10 mg/day and eventually shifted to eplerenone. Despite the optimal dose of eplerenone and
amlodipine, she still experienced severe headaches,
palpitations and breakthrough elevations of BP that
led to her recurrent admissions. Eplerenone was
shifted back to spironolactone (150-200 mg/day)
with amlodipine dose (10 mg/day) normalizing her
blood pressure and potassium level, yet with persistent headache and muscle weakness. Repeat imaging using CT scan with contrast showed consistent
results. Postoperatively, with all medications discontinued the patient was asymptomatic, normotensive (110/70 mmHg) and normokalemic (4.0 mmol/L).
One month later, her BP started to increase again at
140/80 mmHg and her K decreased to 3.4 mmol/L.
Normalization of said parameters (BP:120/70
mmHg K: 4.1 mmol/L), with stabilization following
lower doses of amlodipine (5mg/day) and spironolactone (25 mg/day). Also, all the symptomatology
of the patient resolved completely.
Conclusion
This present case exemplifi es a unilateral adrenalectomy approach in BAH, which
led to improvement in BP and K levels, despite low
medication doses. Furthermore, symptom relief and
improved quality of life, as desired outcomes, were
achieved.
Hypertension
;
Hyperaldosteronism
5.Severe Pericardial Effusion due to autoimmune Hypothyroidism with Levothyroxine withdrawal and systemic Lupus Erythematosus
Sylvernon Israel ; Katherine Ann Tan ; Ma. Felisse Carmen Gomez ; Florence Rochelle Gan ; Jean Uy-Ho
Journal of the ASEAN Federation of Endocrine Societies 2022;37(2):83-88
The presence of autoantibodies is a common link between autoimmune hypothyroidism (AH) and Systemic Lupus Erythematosus (SLE). The coexistence of AH (Hashimoto’s Thyroiditis) and SLE is common; however, massive pericardial effusion (PEEF) with signs of tamponade is extremely rare and only a few cases have been reported in literature. We present a case of a 54-year-old female who came in with progressive dyspnea who was found out to have massive PEEF from overt AH and concurrent SLE, which was successfully managed medically. This gave us valuable insight that massive pericardial effusion occurring in overt hypothyroidism may be secondarily caused by other co-existing disease entities such as SLE. The importance of the correct diagnosis cannot be overemphasized, as this largely contributed to the successful management of this case.
Pericardial Effusion
;
Cardiac Tamponade
;
Lupus Erythematosus, Systemic